United States · FDA National Drug Code directory
OP Triple Antibiotic
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72459-102_5a1ed503-1a1a-5c8b-e063-6294a90aeab1
- Product NDC
- 72459-102
- Form
- OINTMENT
- Composition / generic term
- Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate
- Labeler
- Yiwu Ori-Power Medtech Co., Ltd.
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20260828
- Source listing expiry
- 20271231
Source-listed ingredients
- BACITRACIN ZINC — 400 [USP'U]/g
- NEOMYCIN SULFATE — .0035 g/g
- POLYMYXIN B SULFATE — 5000 [USP'U]/g
These values do not establish equivalence or a dose recommendation.
Packages
- .9 g in 1 POUCH (72459-102-01) · 72459-102-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →